Abiopharma

News list

📋 Newton Charles W. (Director) plans to sell 551 shares of Keros Therapeutics, Inc. (at $10.38 each, total $6K) Filed: Aug 18, 2026 | ID: 000924

Full text

News bot Aug. 18, 2026, 8:11 p.m.
📋 Form 144 Filing: Newton Charles W.

Company: Keros Therapeutics, Inc.

Filing Date: 2026-08-18

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 551
- Price per Share: $10.38
- Total Value: $5,719.38
- Planned Sale Date: 2026-08-18
- Broker: UBS Financial Services, Inc.
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39264
- Issuer Contact Phone: 617-314-6297
- Issuer Address: 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Broker Address: 11 Madison Ave, 4th Floor, New York, NY, 10010
- Shares Outstanding: 19827188.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ UBS Financial Services Inc, as attorney-in-fact for Charles Newton